The Year DEA Prescriber Agent: New Interpretation What it means to you! Richard B Greene, PharmD, MBA, FASCP 1

Size: px
Start display at page:

Download "The Year DEA Prescriber Agent: New Interpretation What it means to you! Richard B Greene, PharmD, MBA, FASCP 1"

Transcription

1 Disclaimer DEA: Prescriber Agent: New Policy, New Interpretation Richard B. Greene, PharmD, MBA, FASCP ARX Consulting I, Richard B. Greene, do not have any real or apparent commercial affiliations related to the content of this presentation. 2 Objectives Describe the current interpretations of Drug Enforcement Administration (DEA) rules regarding the prescribing and dispensing of controlled substances Define Agent of the Prescriber as it relates to prescribing of controlled substances. Distinguish the difference between the controlled substance regulations for longterm care residents, hospice patients and other patients Identify the documentation required to ensure pharmacy compliance with the DEA regulations. 3 The Year 1970 Gas was 36 a gallon The EPA was created The Beatles broke-up Child resistant caps required in retail pharmacy The World Trade Center was completed Lithium was approved for Manic Depression Bar Codes, Floppy Disks and were not available yet. Controlled Substance Act passed 4 Federal Controlled Substances Law Prescriptions for Controlled Dangerous Substances Purpose of issue Rx must be for legitimate medical purpose (21 CFR (a)) Practices which alert RPh to unauthorized or inappropriate prescribing Larger quantities prescribed by a prescriber as compared to other prescribers of the same specialty Dose, quantity, combination drugs outside of accepted medical practice Irrational combinations frequently prescribed Patients travel to pharmacy to have prescription filled Erasures, misspellings, hospital Rx s (esp. VA Medical Centers) alterations Nonexistent person 5 Required Elements of a Valid Written Prescription for a Controlled Substance (21CFR ) Full name of the patient Full address of the patient (not just the facility name) Pharmacist must fill in if missing Drug name strength & dosage form Drug name, strength, & dosage form Directions for use Quantity prescribed (some states may require alpha & numeric notation of quantity) Full name, full address, & DEA number of the practitioner Date issued & Manual prescriber signature 6 Richard B Greene, PharmD, MBA, FASCP 1

2 Changes a pharmacist CAN NOT make to a Schedule II prescription DEA states that "the essential elements of the [Schedule II] prescription written by the practitioner (such as the name of the controlled substance, strength, dosage form, and quantity prescribed) may not be modified orally. Instructions are in opposition to DEA's previous policy which permitted the same changes a pharmacist may make to schedules CIII-V prescriptions after oral consultation with the prescriber. 7 Who may Prescribe a Scheduled Substance? A prescription order for a controlled substance may be issued only by a physician, dentist, podiatrist, veterinarian, mid-level practitioner or other registered practitioner who is: 1. Authorized to prescribe controlled substances by the jurisdiction in which he/she is licensed to practice. 2. Registered with DEA or exempted from registration (i.e., Public Health Service and Bureau of Prison physicians). 8 Mid Level Practitioners Permitted by the United States or the jurisdiction in which he/she practices DEA Mid Level Practitioner Web Site reg/practioners/index.html Examples: nurse practitioners, nurse midwives, nurse anesthetists, clinical nurse specialists, physician assistants, and pharmacists. 9 Mid Level Practitioners AMB Ambulance Service AS Animal Shelters DOM Doctors of Oriental Medicine ET Euthanasia Technicians HMD Homeopathic Physician MP Medical Psychologists ND Naturopathic Physician NP Nurse Practitioners NH Nursing Homes OD Optometrists PA Physician Assistants RPH Registered Pharmacists 10 Use of Hospital s DEA A practitioner (e.g., intern, resident, staff physician, mid-level practitioner) who is an agent or employee of a hospital or other institution May administer, dispense or prescribe controlled substances under the registration of the hospital or other institution in which he or she is employed provided that: Criteria for the Use of Hospital s DEA The hospital or institution authorizes the practitioner to dispense or prescribe under its registration and assigns a specific internal code number for each practitioner so authorized Richard B Greene, PharmD, MBA, FASCP 2

3 C have Controlled Substance Schedules The drugs and drug products under the jurisdiction of the CSA are divided into five schedules. Controlled substances in Schedules II-V have an accepted medical use in the United States, and Schedule I substances do not. 13 Scheduling of C Schedule I Cannot be prescribed Schedule II High potential for abuse Schedule III Less abuse potential than Schedule II Schedule IV Low abuse potential relative to Schedule III Schedule V Low abuse potential relative to Schedule IV CI CII CIII CIV - CV CFR Requirement of Prescription (a) A pharmacist may dispense directly a controlled substance listed in Schedule II that is a prescription drug as determined under section 503 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353(b)) only pursuant to a written prescription signed by the practitioner, except as provided in paragraph (d) of this section. Schedule II A CII drug may only be dispensed pursuant to a valid Written prescription, signed by the practitioner and must list: The full name and address of the patient Drug name, strength, dosage form, quantity prescribed and directions for use Name, address and registration number of the practitioner Practitioner s signature Federal Controlled Substances Law Prescriptions for Controlled Dangerous Substances The Act and Drug Enforcement Administration regulations contain no specific limits on the number of days worth of a Schedule II controlled substance that a physician may authorize per prescription. Multiple Schedule II prescriptions (Interpretation of CFR ) DEA s regulations allow practitioners to provide individual patients with multiple prescriptions for a specific Schedule II CS, written on the same date, to be filled sequentially. The combined effect of such sequential multiple prescriptions is that it allows a patient to receive over time up to a 90-day supply of that CS Richard B Greene, PharmD, MBA, FASCP 3

4 Emergency prescription (d) In the case of an emergency situation, as defined by the Secretary in of this title, a pharmacist may dispense a controlled substance listed in Schedule II upon receiving oral authorization of a prescribing individual practitioner, provided that: Federal Controlled Substances Law Prescriptions for Controlled Dangerous Substances Scheduled II dispensing requirements Emergency oral CII prescriptions All 3dee determinations must be made (21 CFR ) Emergency administration of CII is needed for patient care No proper alternative available Not readily possible for prescriber to present a written Rx prior to dispensing Federal Controlled Substances Law Prescriptions for Controlled Dangerous Substances Scheduled II dispensing requirements (continued) Emergency oral CII prescriptions (continued) When receiving emergency oral CII RPh must Reduce Rx to writing with all required information Make reasonable effort to determine prescriber s authority (if not known) (i.e., call back) Emergency CII prescription (21 CFR ) A pharmacist MUST receive the written prescription within 7 days from an oral authorization The prescription should include: A Notation: Authorization for Emergency Dispensing Date of oral authorization If the information is not received within 7 days, the pharmacist is required to report this missing information to the DEA Emergency CII prescription (21 CFR ) Dispensing beyond the emergency period requires a written prescription signed by the individual practitioner. Schedule II (continued) Emergency Kits Must have valid written Rx unless the Emergency Rule applies E-Kits should never be used routinely to dispense drugs that should have been reordered E-Kits are not starter doses E-Kits should only be used for unanticipated emergencies Richard B Greene, PharmD, MBA, FASCP 4

5 Federal Controlled Substances Law Prescriptions for Controlled Dangerous Substances Scheduled II dispensing requirements Except in emergency only pursuant to valid, written Rx Only valid for 30 days Do not fill in the date if it is missing Can be faxed if have original prescriptions before dispensing 25 DEA Regulations CFR (g) A prescription prepared in accordance with written for a Schedule II narcotic substance for a patient enrolled in a hospice care program certified and/or paid for by Medicare under Title XVIII or a hospice program which is licensed by the state may be transmitted by the practitioner or the practitioner's agent to the dispensing pharmacy by facsimile. The practitioner or the practitioner's agent will note on the prescription that the patient is a hospice patient. The facsimile serves as the original written prescription for purposes of this paragraph (g) and it shall be maintained in accordance with (h). 26 Schedule II (continued) Facsimile Only for residents in long-term care or in a Medicare hospice program Fax must meet all of the requirements e e of a valid, written prescription order (including the signature of the practitioner). For hospice patients, prescription must state hospice patient. May be transmitted only by practitioner or the practitioner s agent Federal Controlled Substances Law Prescriptions for Controlled Dangerous Substances Scheduled II dispensing requirements (continued) Partial filling CII (21 CFR ) When full quantity not available Must note partial filling on Rx; date and quantity Must complete order with 72 hours but if not, must notify prescriber and receive new Rx Exceptions for long-term care facilities or hospice patients DEA Regulations CFR Section Partial filling of prescriptions. (b) A prescription for a Schedule II controlled substance written for a patient in a Long Term Care Facility (LTCF) or for a patient with a medical diagnosis documenting a terminal illness may be filled in partial quantities to include individual dosage units.. The pharmacist must record on the prescription whether the patient is "terminally ill" or an "LTCF patient.". The total quantity of Schedule II controlled substances dispensed in all partial fillings must not exceed the total quantity prescribed. 29 Emergency CII Prescription Review A Schedule II controlled substance medication requires a written prescription from the practitioner, except in the case of an emergency. In an emergency, the pharmacist can dispense a Schedule II controlled substance medication upon receiving oral authorization from the practitioner. Emergency dispensing of a Schedule II controlled substance must be limited to the amount adequate to treat the patient during the emergency period. The practitioner must deliver a signed written prescription to the pharmacy within seven (7) days after orally authorizing an emergency prescription. (Some states may require a stricter guideline of 72 hours after authorizing an emergency oral prescription.) 30 Richard B Greene, PharmD, MBA, FASCP 5

6 Schedule III, IV and V Can be dispensed only pursuant to: A valid written prescription signed by the practitioner, A facsimile of a written, signed prescription transmitted to the pharmacy by the practitioner or the practitioner s agent, or Pursuant to an oral prescription made by an individual practitioner and promptly reduced to writing by the pharmacist containing all information required for a valid prescription, such as authorized refills, except for the signature of the practitioner 31 Section Requirement of prescription. (a) A pharmacist may dispense directly a controlled substance listed in Schedule III, IV, or V that is a prescription drug as determined under section 503(b) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353(b)) only pursuant to either a paper p prescription p signed by a practitioner, a facsimile of a signed paper prescription transmitted by the practitioner or the practitioner's agent to the pharmacy, an electronic prescription that meets the requirements of this part and part 1311 of this chapter, or an oral prescription made by an individual practitioner and promptly reduced to writing by the pharmacist containing all information required in Sec , except for the signature of the practitioner. 32 Section Refilling of prescriptions. (a) No prescription for a controlled substance listed in Schedule III or IV shall be filled or refilled more than six months after the date on which such prescription was issued. No prescription p for a controlled substance listed in Schedule III or IV authorized to be refilled may be refilled more than five times. Section Refilling of prescriptions. The prescribing practitioner may authorize additional refills of Schedule III or IV controlled substances on the original prescription through an oral refill authorization transmitted to the pharmacist provided that the total quantity authorized, including the amount of the original prescription, does not exceed five refills nor extend beyond six months from the date of issue of the original prescription Review Schedule III-V Schedule CIII-V prescription requirements: 1) A written prescription signed by a practitioner, or 2) A fax of a written, signed prescription transmitted by the practitioner or the practitioner s agent to the pharmacy, or 3) An oral prescription communicated by the practitioner or the practitioner s agent to a pharmacist. A Schedule III-V controlled substance medication can have five (5) refills in a six (6) month period. A Schedule III-V controlled substance cannot be filled or refilled more than six (6) months after the date on which the prescription was issued. 35 Review Schedule III-V A partial fill of a Schedule III-V prescription is allowed, provided that: 1) Each partial filling is recorded in the same manner as a refilling, 2) The total quantity dispensed in all partial fills does not exceed the total quantity prescribed, and 3) No dispensing occurs after six (6) months from the date on which the prescription was issued. According to the Drug Enforcement Administration (DEA): the practitioner may, in writing, authorize an agent to prepare a controlled substance prescription only based on the instructions of the prescribing practitioner as to the required elements of a valid prescription, and then provide the prescription to the practitioner to review and personally sign. 36 Richard B Greene, PharmD, MBA, FASCP 6

7 Transfer Schedule III, IV and V Prescriptions Refills One time basis only Transfer is communicated directly between two licensed pharmacists Void on Rx Record on reverse side invalidated Rx Name, address and DEA registration of the pharmacy transferred Name of pharmacist receiving Date of the transfer and the name of the pharmacists transferring 37 Transfer Schedule III, IV and V Prescriptions (Continued) Pharmacist receiving Transfer on the face of the Rx Provide all Rx information, date of issuance of original, original number of refills, date of original dispensing, number of refills remaining, and dates and locations of previous refills Name, address, DEA registration, and Rx number from which transferred Name of pharmacist who transferred Name, address, DEA registration, and Rx number from which originally filled Maintain for 3 years from date of last fill Electronically accessing the same Rx record must satisfy all requirements of a manual transfer 38 Communicating Prescriptions Only an individual practitioner can issue But once prepared, a valid prescription may be communicated to a pharmacist by: An employee, or An agent of the individual employee. Agent means: an authorized person who acts on behalf of or at the direction of a manufacturer, distributor, or dispenser; except that such term does not include a common or contract carrier, public warehouseman, or employee or the carrier or warehouseman, when acting in the usual and lawful course of the carrier s or warehouseman s business Interpretation of Agent Practitioner s nurse Practitioner s secretary An employee of LTCF is not an agent of the practitioner Legacy Order Process Prescriber communicates order to facility staff (written, phone, fax, electronic) Facility transmit the order to the pharmacy Pharmacy fills the order and delivers. Pharmacy then starts t trying to contact t the physician for the prescription Pharmacy continued to reach out until the issue was resolved Richard B Greene, PharmD, MBA, FASCP 7

8 Leading Events 1. In April 2009 the Drug Enforcement Administration (DEA) conducted audits in the Cleveland area, 2. DEA Interpretation: The DEA does NOT recognize the Nursing Facility nurse as an agent of the physician and does NOT see the chart order as a legitimate order for a controlled substance in a Nursing Facility, 3. If the pharmacy does not have a faxed complete Controlled Substance prescription, OR does not have a direct verbal authorization from the prescriber to a pharmacist, Nurses can NOT administer the Controlled Substance from the facility CS EDK and the pharmacy can NOT fill the order. 43 Multi-Million dollar fines and penalties being levied 2008 and 2009 $58,000,000 in fines and numerous registration actions Several large pending cases Pharmacy Manufacturer Distributor 44 Federal Register / Vol. 75, No. 193 / Wednesday, October 6, 2010 / Rules and Regulations (page ) Penalties and Fines Administrative sanctions; Letter of Admonition Administrative Hearing Loss of Registration DOJ Civil Prosecution. Consent Decree. Fines DOJ Criminal Prosecution. Fine. Jail. Forfeiture Board of Pharmacy Action. Licensure DEA Policy Clarification October 6 Federal Register DEA defines agent and expands interpretation beyond employees of a physician Policy applies to CIII-CV C controlled o medications LTCF nurse designated agent OR other designee may telephone orders to pharmacy on behalf of prescribing physician Written agreement between physician and designee establishing agency Must have separate documentation allowing agency to be rescinded 47 Agent of Prescriber Schedule II Prescriptions According to the Drug Enforcement Administration (DEA): the practitioner may, in writing, authorize an agent to prepare a controlled substance prescription only based on the instructions of the prescribing practitioner as to the required elements of a valid prescription, and then provide the prescription to the practitioner to review and personally sign. The agent of the practitioner may not orally communicate a Schedule II controlled substance order to the pharmacy under any circumstances. 48 Richard B Greene, PharmD, MBA, FASCP 8

9 Agent of Prescriber Schedule III, IV, V Prescriptions DEA issued a clarification to allow nurses in LTC or other prescriber designees to act as the prescriber s agent for C-III, IV, and CV and communicate the prescription to the pharmacy Must designate everyone individually not a facility No help for emergency prescriptions No help with chart orders 49 Revocation of the Agency Agreement Because the agency agreement may be revoked at any time by either the practitioner or by the agent, the party terminating the agreement should notify the other party immediately upon termination. The practitioner should notify those pharmacies that were originally made aware of the agency agreement of the termination of that agreement. In most circumstances where the agent changes employment, the agreement should be revoked. 50 Revocation of the Agency Agreement The agency agreement shall be terminated immediately if and when any of the following occur: The prescribing practitioner no longer possesses the active DEA registration specified in the agreement. The agent of the practitioner is no longer employed in the manner described in the agreement. The prescribing practitioner or the authorized agent revokes the agency agreement by completing the revocation section of the agency agreement, or by executing a written document that is substantially similar to the revocation section at the end of the agency agreement. 51 Agency Agreement Federal Register (sample) Federal Register provides a sample agent agreement that is available for use by practitioners and nurses. This document is formatted as outlined in the DEA statement of policy articulated in the Federal Register, and is provided as a template for the practitioneragent agreement. Agreement must contain the elements outlined in the Federal Register, must be signed by the prescribing practitioner and the authorized agent for the purposes of recognizing the facility nurse as an agent of the prescribing practitioner for the purposes of communicating controlled substance prescriptions to pharmacies Richard B Greene, PharmD, MBA, FASCP 9

10 Agent of the Practitioner s Role The role of the authorized agent of the practitioner depends upon: The schedule of the controlled substance prescribed The circumstances of the ultimate user The method of communication Agent Activities The agent of the practitioner is a person authorized in a written, practitioner-signed agent agreement, to perform certain ministerial acts in connection with communicating gprescription p information to a pharmacy. The most common means to communicate a prescription to the pharmacy include: Hand delivery Facsimile (FAX) Telephone call Agent of the Practitioner s Role: Schedule II An authorized agent of the practitioner may transmit a practitioner-prepared and practitionersigned Schedule II controlled substance paper prescription via facsimile to the pharmacy on behalf of the practitioner. An authorized agent of the practitioner may prepare a Schedule II controlled substance prescription based on the instructions of the prescribing practitioner as to the required elements of a valid prescription, provide the prescription to the practitioner to review and personally sign, then transmit the prescription via facsimile to the pharmacy on behalf of the practitioner. 57 Agent of the Practitioner s Role: Schedule II An authorized agent of the practitioner may transmit a practitioner-signed valid Schedule II controlled substance prescription, on behalf of the practitioner, to a pharmacy via facsimile for: Patients enrolled in a hospice care program certified and/or paid for by Medicare under Title XVIII. Patients enrolled in a hospice program which is licensed by the State. Residents of Long Term Care Facilities (LTCFs). An authorized agent of the practitioner may not orally communicate a Schedule II controlled substance to a pharmacist under any circumstances. 58 Agent of the Practitioner s Role: Schedule III-V An authorized agent of the practitioner may transmit a practitioner-prepared and practitioner-signed Schedule III-V controlled substance paper prescription to the pharmacy on behalf of the practitioner. An authorized agent of the practitioner may prepare a Schedule III-V controlled substance prescription only based on the instructions of the prescribing practitioner as to the required elements of a valid prescription, and then provide the prescription to the practitioner to review and personally sign. An authorized agent of the practitioner may orally communicate a Schedule III-V controlled substance prescription, made by an individual practitioner, to a pharmacist. 59 Agent of the Practitioner Agreement A regulatory clarification, issued by the DEA as a statement of policy in the Federal Register on October 6, 2010, publicly articulates that an agent agreement must be established between the agent and the prescribing practitioner in order for the agent to act as an authorized agent of the prescribing practitioner. Once this agreement has been executed, the authorized agent of the prescribing practitioner can perform all of the agent functions described in the previous slides. It is important that the authorized agent of the prescribing practitioner be clearly identified as a designated individual person, and that his or her activities be subject to evaluation to ensure that they do not exceed the bounds of an agent s role under 60 the Act. Richard B Greene, PharmD, MBA, FASCP 10

11 Agent of the Practitioner Agreement A practitioner, acting in the usual course of his or her professional practice, must determine that there is legitimate medical purpose for a controlled substance prescription. The authorized agent of the prescribing practitioner may not make the determination that there is a legitimate medical purpose for a controlled substance prescription. Where the pharmacist has reason to believe that a prescription has been communicated by an agent, the pharmacist, in accordance with his or her responsibility for proper dispensing of controlled substances, may have a duty to inquire into the legitimacy of the prescription. The particular circumstances will dictate the appropriate level of 61 inquiry by the pharmacist. Agent of the Practitioner Agreement DEA recommends that the original agency agreement be kept by the practitioner during the term of the agency relationship, and for a reasonable time after termination or revocation. DEA requires that inventory and other records be kept for at least two years; this is a suggested time period for retention of agency agreements, but is not required by DEA. A signed copy should also be provided to the prescribing practitioner s authorized agent, the agent s employer, and any pharmacies that receive regular communications from the agent pursuant to the agreement. 62 Agent of the Practitioner Agreement Role of the Pharmacist A pharmacist always has a corresponding responsibility to ensure that a controlled substance prescription conforms with the law and regulations. The pharmacist also has a corresponding responsibility to ensure that the prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice, and a corresponding liability if a prescription is not prepared or dispensed in a manner consistent with CSA or DEA regulations. Even when the pharmacist has a copy of the agency agreement, the pharmacist may also have a duty to inquire further depending on the circumstances. 63 DEA Policy Statement Review Role of Authorized Agents in Communicating Controlled Substance prescriptions to pharmacies Policy statement published in Federal Register: October 6, s/rules/2010/fr1006.htm Provides guidance to establish valid agency to communicate prescriptions 64 What Can You Do to Help Your Patients Get Their Medication? Consult with your practitioners about executing agent agreements for designees. A separate agreement must be executed and signed for each practitioner and each agent. Request signed, written prescriptions from practitioners for all controlled substance medications that are ordered for facility residents, especially new Schedule II controlled substance medications and Schedule III-V controlled substance medications that are new or have no refills. Remind practitioners to authorize a sufficient quantity of Schedule II controlled substance medication for your patients, especially for prn orders. Remind practitioners to authorize refills on Schedule III-V controlled substance medications for your patients. 65 What Can You Do to Help Your Residents Get Their Medication? Remind hospital Discharge Planners to encourage practitioners to transfer new residents to your facility with signed, written prescriptions for all controlled substance medications. Remind facility staff: The pharmacy owns the e-kit inventory The use of contingency supply/emergency box/starter kit/automated dispensing machine controlled substance medications requires prior authorization by the pharmacist. Facility must contact the pharmacist prior to removing a controlled substance medication from the contingency supply, and must have authorization from the pharmacist prior to removing a controlled substance medication from the contingency supply. Consult the staff pharmacist, consultant pharmacist, or your practitioner regarding the possible use of noncontrolled pain medications for your 66 residents. Richard B Greene, PharmD, MBA, FASCP 11

12 Agency Policy Applicable to: Oral schedules III-V prescriptions Faxing of manually signed schedules III-V Preparing a schedule II prescription for prescriber signature Faxing of schedule II prescription for a person in a hospice or long term care facility Agency policy Includes sample written agency agreement to confirm authority Practitioner may designate one or more persons Agent may not further delegate authority Includes revocation language Recommendations for Change Allow nurses in LTCF and hospice to act as agents of prescribers to transmit Schedule II-V CS orders Expand the definition of a valid prescription drug order to include chart orders for patients in LTCFs and hospice Design a new category of DEA registration that allows facilities to be custodians of controlled substances. 69 References USA Department of Justice Drug Enforcement Administration Office of Diversion Control DEA Pharmacist Manual Code of Federal Regulations Title 21 CFR, Part American Society of Addiction Medicine's (ASAM) American Academy of Pain Medicine (AAPM) University of Wisconsin Pain & Policy Studies Group: 70 Thank you for your participation! DEA: Prescriber Agent: New Policy, New Interpretation Richard B. Greene, PharmD, MBA, FASCP ARX Consulting rbgreene7@gmail.com Richard B Greene, PharmD, MBA, FASCP 12

Federal Regulations For Prescribing Scheduled Controlled Substances

Federal Regulations For Prescribing Scheduled Controlled Substances Federal Regulations For Prescribing Scheduled Controlled Substances HEIT TEMPLATE.PPT 1 Central Principle of Balance With the Use of Controlled Substances Dual imperative of government Establish a system

More information

Exceptions to the Rule: A Pharmacy Law Presentation. Objectives DISCLAIMER 10/16/2015

Exceptions to the Rule: A Pharmacy Law Presentation. Objectives DISCLAIMER 10/16/2015 Exceptions to the Rule: A Pharmacy Law Presentation Eric Roath, Pharm.D. Director of Professional Practice Michigan Pharmacists Association Objectives 1. Identify basic legal frameworks that govern the

More information

Who is the DEA? New Narcotic Regulations and How They Affect Your Assisted Living Facility. 2009 DEA Audits. Scheduled/Controlled Drugs

Who is the DEA? New Narcotic Regulations and How They Affect Your Assisted Living Facility. 2009 DEA Audits. Scheduled/Controlled Drugs Who is the DEA? New Narcotic Regulations and How They Affect Your Assisted Living Facility Nancy Lamb RPh Good Day Pharmacy DEA- Drug Enforcement Administration This is not the State Health Department

More information

SECTION.1800 - PRESCRIPTIONS

SECTION.1800 - PRESCRIPTIONS SECTION.1800 - PRESCRIPTIONS 21 NCAC 46.1801 EXERCISE OF PROFESSIONAL JUDGMENT IN FILLING PRESCRIPTIONS (a) A pharmacist or device and medical equipment dispenser shall have a right to refuse to fill or

More information

Controlled II Substance Rules & Regulations. Controlled II Substance Rules & Regulations

Controlled II Substance Rules & Regulations. Controlled II Substance Rules & Regulations North Carolina Board of Pharmacy Controlled Substance Pocketcard A brief summary of pertinent rules and regulations impacting the practice of pharmacy ~ Controlled II Substance Controlled II Substance

More information

PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA

PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA PRESCRIPTION MONITORING PROGRAM STATE PROFILES LOUISIANA Research current through July 2014. This project was supported by Grant No. G1399ONDCP03A, awarded by the Office of National Drug Control Policy.

More information

Drug Diversion. Controlled Substance Prescribing and Diversion

Drug Diversion. Controlled Substance Prescribing and Diversion Drug Diversion Provider Presentation Controlled Substance Prescribing and Diversion Angela Wallace, R.Ph. Coastal District Inspector, PMP Law Enforcement Officer DHEC Bureau of Drug Control Presentation

More information

Mid-Level Practitioners Authorization by State

Mid-Level Practitioners Authorization by State Mid-Level Practitioners Authorization by State Pursuant to Title 21, Code of Federal Regulations, Section 1300.01(b28), the term mid-level practitioner means an individual practitioner, other than a physician,

More information

ARKANSAS DEPARTMENT OF HEALTH

ARKANSAS DEPARTMENT OF HEALTH ARKANSAS DEPARTMENT OF HEALTH PHARMACY SERVICES AND DRUG CONTROL BRANCH RULES AND REGULATIONS PERTAINING TO CONTROLLED SUBSTANCES December 1, 2014 I, James Myatt, P.D., Director, Pharmacy Services and

More information

ROCHESTER AREA SCHOOL DISTRICT

ROCHESTER AREA SCHOOL DISTRICT No. 210 SECTION: PUPILS ROCHESTER AREA SCHOOL DISTRICT TITLE: USE OF MEDICATIONS ADOPTED: August 11, 2008 REVISED: August 25, 2014 210. USE OF MEDICATIONS 1. Purpose The Board shall not be responsible

More information

ENROLLED SENATE BILL No. 92

ENROLLED SENATE BILL No. 92 Act No. 285 Public Acts of 2014 Approved by the Governor September 23, 2014 Filed with the Secretary of State September 23, 2014 EFFECTIVE DATE: December 22, 2014 STATE OF MICHIGAN 97TH LEGISLATURE REGULAR

More information

NH Laws / Rules Regarding Limited Retail Drug Distributors

NH Laws / Rules Regarding Limited Retail Drug Distributors NH Laws / Rules Regarding Limited Retail Drug Distributors 318:1, VII-a. "Limited retail drug distributor'' means a distributor of legend devices or medical gases delivered directly to the consumer pursuant

More information

House Study Bill 503 - Introduced

House Study Bill 503 - Introduced House Study Bill 0 - Introduced HOUSE FILE BY (PROPOSED COMMITTEE ON HUMAN RESOURCES BILL BY CHAIRPERSON MILLER) A BILL FOR An Act relating to prescription authority for certain psychologists and making

More information

How To Write A Prescription In California

How To Write A Prescription In California Competitive PR4 PHONE & FAX 916-760-4477 2443 FAIR OAKS BLVD. #322, SACRAMENTO, CA 95825 WWW.CPR4RX.COM CPR4RX@CPR4RX.COM CA CONTROLLED SUBSTANCE RX REFERENCE GUIDE May 2013 Table of Contents Requirements

More information

Michael D. Bullek BSP Rph. Commissioner, New Hampshire Board of Pharmacy

Michael D. Bullek BSP Rph. Commissioner, New Hampshire Board of Pharmacy Michael D. Bullek BSP Rph. Commissioner, New Hampshire Board of Pharmacy Legislative changes PDMP program changes 503B outsourcing facilities Rules changes Ph800 review Ph300 Ph400 Ph700 Current issues

More information

FERNDALE AREA SCHOOL DISTRICT

FERNDALE AREA SCHOOL DISTRICT No. 210 SECTION: PUPILS FERNDALE AREA SCHOOL DISTRICT TITLE: MEDICATIONS ADOPTED: AUGUST 1985 REVISED: DECEMBER 6, 2000 MAY 9, 2007 JUNE 17, 2009 JUNE 18, 2014 210. MEDICATIONS REVISED: 1. Purpose The

More information

247 CMR: BOARD OF REGISTRATION IN PHARMACY

247 CMR: BOARD OF REGISTRATION IN PHARMACY 247 CMR 9.00: CODE OF PROFESSIONAL CONDUCT; PROFESSIONAL STANDARDS FOR REGISTERED PHARMACISTS, PHARMACIES AND PHARMACY DEPART- MENTS Section 9.01: Code of Professional Conduct for Registered Pharmacists,

More information

RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS

RULES OF THE TENNESSEE BOARD OF NURSING CHAPTER 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES OF FITNESS TO PRESCRIBE TABLE OF CONTENTS RULES OF THE TENNESSEE BOARD OF NURSING R 1000-04 ADVANCED PRACTICE NURSES AND CERTIFICATES TABLE OF CONTENTS 1000-04-.01 Purpose and Scope 1000-04-.07 Processing of Applications 1000-04-.02 Definitions

More information

EPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: January 2016

EPCS FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES. Revised: January 2016 FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: January 2016 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic

More information

Prepared By: The Professional Staff of the Committee on Health Policy REVISED:

Prepared By: The Professional Staff of the Committee on Health Policy REVISED: BILL: SB 152 The Florida Senate BILL ANALYSIS AND FISCAL IMPACT STATEMENT (This document is based on the provisions contained in the legislation as of the latest date listed below.) Prepared By: The Professional

More information

SCOPE OF PRACTICE FOR ARNPS

SCOPE OF PRACTICE FOR ARNPS FLORIDA'S PROHIBITION ON ADVANCED REGISTERED NURSE PRACTITIONERS (ARNPs) PRESCRIBING CONTROLLED SUBSTANCES AND THE REQUIREMENTS TO REPORT SUCH ACTIVITY Florida is one of the two states that does not allow

More information

Donald H. Williams, Pharmacy Board. D. E. A. Rules 21 C.F.R. 1300. DEA Rules - Objectives. DEA Rules

Donald H. Williams, Pharmacy Board. D. E. A. Rules 21 C.F.R. 1300. DEA Rules - Objectives. DEA Rules D. E. A. Rules 21 C.F.R. 1300 Everything that you need to know but were afraid to ask DEA Rules - Objectives The student will be able to discuss the manner in which the DEA regulates the distribution of

More information

Advanced Practice Nurses Authority to Diagnose and Prescribe

Advanced Practice Nurses Authority to Diagnose and Prescribe Advanced Practice Nurses Authority to Diagnose and Prescribe ted ec ot. r p e ht ion th rig mat of ty y r y p s o cie Co inf rte So u l o a dc dic ide Me e t a St ois v ro P n Illi www.isms.org ADVANCED

More information

No. 39. An act relating to patient choice and control at end of life. (S.77) It is hereby enacted by the General Assembly of the State of Vermont:

No. 39. An act relating to patient choice and control at end of life. (S.77) It is hereby enacted by the General Assembly of the State of Vermont: No. 39. An act relating to patient choice and control at end of life. (S.77) It is hereby enacted by the General Assembly of the State of Vermont: Sec. 1. 18 V.S.A. chapter 113 is added to read: CHAPTER

More information

CURES Prescription Drug Monitoring Program

CURES Prescription Drug Monitoring Program California Department of Justice CURES Prescription Drug Monitoring Program February, 2013 The mission of the California Prescription Drug Monitoring Program (PDMP) is to eliminate pharmaceutical drug

More information

02- DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION. Chapter 8 REGULATIONS RELATING TO ADVANCED PRACTICE REGISTERED NURSING

02- DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION. Chapter 8 REGULATIONS RELATING TO ADVANCED PRACTICE REGISTERED NURSING 02- DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION 380 BOARD OF NURSING Chapter 8 REGULATIONS RELATING TO ADVANCED PRACTICE REGISTERED NURSING SUMMARY: This chapter identifies the role of a registered

More information

CHAPTER 74. 1. Section 34 of P.L.1970, c.226 (C.24:21-34) is amended to read as follows:

CHAPTER 74. 1. Section 34 of P.L.1970, c.226 (C.24:21-34) is amended to read as follows: CHAPTER 74 AN ACT concerning drug abuse, revising various parts of the statutory law, and supplementing P.L.2007, c.244. BE IT ENACTED by the Senate and General Assembly of the State of New Jersey: 1.

More information

Louisiana Administrative Code. Title 46 Professional and Occupational Standards. Part LIII: Pharmacists

Louisiana Administrative Code. Title 46 Professional and Occupational Standards. Part LIII: Pharmacists Chapter 17. Institutional Pharmacy Louisiana Administrative Code Title 46 Professional and Occupational Standards Subchapter A. General Requirements Part LIII: Pharmacists 1701. Cross References A. For

More information

California State Board of Pharmacy and Medical Board of California

California State Board of Pharmacy and Medical Board of California California State Board of Pharmacy and Medical Board of California Transmission and Receipt of Electronic Controlled Substance Prescriptions Pursuant to DEA Interim Final Rule (IFR): Electronic Prescriptions

More information

Definitions: The Certification of Exemption memorandum must be signed by the principal investigator s dean or department chair.

Definitions: The Certification of Exemption memorandum must be signed by the principal investigator s dean or department chair. University of Pittsburgh Guidelines for the Ordering and Use of Prescription Drugs and Devices and Controlled Substances for Non- Clinical Laboratory Research Definitions: 1. Authorized Agent(s) of the

More information

LEGISLATURE OF THE STATE OF IDAHO Sixty-third Legislature Second Regular Session - 2016 IN THE SENATE SENATE BILL NO. 1322

LEGISLATURE OF THE STATE OF IDAHO Sixty-third Legislature Second Regular Session - 2016 IN THE SENATE SENATE BILL NO. 1322 LEGISLATURE OF THE STATE OF IDAHO Sixty-third Legislature Second Regular Session - IN THE SENATE SENATE BILL NO. BY HEALTH AND WELFARE COMMITTEE 0 0 AN ACT RELATING TO EPINEPHRINE AUTO-INJECTORS; AMENDING

More information

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: April 2015 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic

More information

Pharmacy Law Overview. From Civil Liability to Criminal Prosecution

Pharmacy Law Overview. From Civil Liability to Criminal Prosecution Pharmacy Law Overview From Civil Liability to Criminal Prosecution Law That Matters To Pharmacists Robert P. Esgro, R.Ph., Esq. Pharmacy Lawyer and Consultant 610-308-6666 Bob@PharmacyLawyer.com Pharmacy

More information

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015

Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 Achieving Better Care by Monitoring All Prescriptions (ABC-MAP) Act 191 of 2014 Board Meeting April 8, 2015 ABC-MAP Board Meeting Agenda Prescription Drug Monitoring Background ABC-MAP Overview Board Responsibilities

More information

Prescribers required to check PDMP before first prescription for Controled Substances for new patient.

Prescribers required to check PDMP before first prescription for Controled Substances for new patient. State, District, or Territory Alabama Arizona Arkansas Colorado Connecticut Delaware Georgia Guam Criteria for Mandatory Enrollment or Query of PDMP Before renewing an Alabama Controlled Substances Certificate,

More information

Subject: Health; prescription drugs; Vermont Prescription Monitoring 5 System

Subject: Health; prescription drugs; Vermont Prescription Monitoring 5 System 0 Page of S. Introduced by Senator Sears Referred to Committee on Date: Subject: Health; prescription drugs; Vermont Prescription Monitoring System Statement of purpose of bill as introduced: This bill

More information

Pharmacy Operations. Assisting the Pharmacist. Pharmacy Technician Training Systems Passassured, LLC

Pharmacy Operations. Assisting the Pharmacist. Pharmacy Technician Training Systems Passassured, LLC Pharmacy Operations Assisting the Pharmacist Pharmacy Technician Training Systems Passassured, LLC Pharmacy Operations, Assisting the Pharmacist PassAssured's Pharmacy Technician Training Program Pharmacy

More information

3.Prescriber DEA: 4.Board Registration Number: 5.Business Tel:

3.Prescriber DEA: 4.Board Registration Number: 5.Business Tel: Commonwealth of Massachusetts Department of Public Health, Office of Prescription Monitoring and Drug Control 99 Chauncy Street, Boston, MA 02111 Tel: 617-753-7310 Email: mapmp.dph@state.ma.us MA ONLINE

More information

What Every Practitioner Needs to Know About Controlled Substance Prescribing

What Every Practitioner Needs to Know About Controlled Substance Prescribing What Every Practitioner Needs to Know About Controlled Substance Prescribing New York State Department of Health Use of Controlled Substances Controlled substances can be effective in the treatment of

More information

Chapter 11 The Practice of Physician Assistants

Chapter 11 The Practice of Physician Assistants Chapter 11 The Practice of Physician Assistants Scope 100 The following regulations pertain to physician assistants practicing medicine with physician supervision. Physician assistants may perform those

More information

Prescription Drug Monitoring Program. A Powerful Tool

Prescription Drug Monitoring Program. A Powerful Tool Prescription Drug Monitoring Program A Powerful Tool September 16, 2015 No reportable financial interest. Controlled Substance Utilization Review and Evaluation System >16,000 Prescription Painkiller Overdose

More information

11/26/2012. Implementation of Florida s PDMP. Disclosure

11/26/2012. Implementation of Florida s PDMP. Disclosure Implementation of Florida s PDMP Rebecca R. Poston Program Manager December 1, 2012 Disclosure I have no vested interest in or affiliation with any corporate organizations offering financial support or

More information

DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR S OFFICE PHARMACY PROGRAM FOR UTILIZATION OF UNUSED PRESCRIPTION DRUGS

DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR S OFFICE PHARMACY PROGRAM FOR UTILIZATION OF UNUSED PRESCRIPTION DRUGS DEPARTMENT OF LICENSING AND REGULATORY AFFAIRS DIRECTOR S OFFICE PHARMACY PROGRAM FOR UTILIZATION OF UNUSED PRESCRIPTION DRUGS (By authority conferred on the director of the department of licensing and

More information

Please see Section IX. for Additional Information:

Please see Section IX. for Additional Information: The Florida Senate BILL ANALYSIS AND FISCAL IMPACT STATEMENT (This document is based on the provisions contained in the legislation as of the latest date listed below.) BILL: CS/SB 614 Prepared By: The

More information

May 2010 Rhonda Dash, MPH Director, Research Compliance

May 2010 Rhonda Dash, MPH Director, Research Compliance May 2010 Rhonda Dash, MPH Director, Research Compliance Introduce the new Director of Research Compliance Review Applicable Federal Regulations Review Applicable State Regulations Review UNTHSC new Policies

More information

GEORGIA ~ STATUTE. Georgia Code Annotated 16-13-21 (DEA registration); 43-34-100 et seq; 43-34-21 et seq (medical board provisions; PA committee)

GEORGIA ~ STATUTE. Georgia Code Annotated 16-13-21 (DEA registration); 43-34-100 et seq; 43-34-21 et seq (medical board provisions; PA committee) GEORGIA ~ STATUTE STATUTE DATE Enacted 1972 REGULATORY BODY PA DEFINED SCOPE OF PRACTICE PRESCRIBING/DISPENSING SUPERVISION DEFINED Georgia Code Annotated 16-13-21 (DEA registration); 43-34-100 et seq;

More information

OBJECTIVES. ! Understand the rising epidemic of prescription drug abuse in Wyoming. ! Know how to access and use reports from the WORx program

OBJECTIVES. ! Understand the rising epidemic of prescription drug abuse in Wyoming. ! Know how to access and use reports from the WORx program Full source: Wyoming Survey & Analysis Center (2013). Wyoming Prevention Needs Assessment: Interactive Graphing. Laramie, WY: University of Wyoming. (http://pnasurvey.org) Full Source: Wyoming Department

More information

Oregon Prescription Drug Monitoring Program. Terms & Conditions of Account Use Agreement. Statutory Authority:

Oregon Prescription Drug Monitoring Program. Terms & Conditions of Account Use Agreement. Statutory Authority: Oregon Prescription Drug Monitoring Program Terms & Conditions of Account Use Agreement Statutory Authority: The Oregon Health Authority (OHA) was given authority under ORS 431.962 to establish and maintain

More information

Re: Docket No. DEA-218, Electronic Prescriptions for Controlled Substances

Re: Docket No. DEA-218, Electronic Prescriptions for Controlled Substances American Society of Health-System Pharmacists 7272 Wisconsin Avenue Bethesda, Maryland 20814 (301) 657-3000 Fax: (301) 664-8877 www.ashp.org Drug Enforcement Administration Attention: DEA Federal Register

More information

VERMONT2008 Vermont Prescription Monitoring Program

VERMONT2008 Vermont Prescription Monitoring Program VERMONT2008 Vermont Prescription Monitoring Program Report to the Legislature on Act 205 January 15, 2009 108 Cherry Street, PO Box 70 Burlington, VT 05402 1.802.863.7341 healthvermont.gov Vermont Prescription

More information

How To Get A Prescription In Rhode Island

How To Get A Prescription In Rhode Island Controlled Substance Prescribing Laws, The Prescription Monitoring Program, and Preventing Drug Diversion Michael Halse, PharmD PGY1 Resident Pharmacist South County Hospital and Healthcare System Disclosures

More information

ADMINISTRATION OF MEDICATIONS POLICY

ADMINISTRATION OF MEDICATIONS POLICY Policy 6.007. ADMINISTRATION OF MEDICATIONS POLICY It is the policy of Cooperative Educational Services (C.E.S.) that students who require any medications to be administered during school hours, including

More information

HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR. 1) Health Care Mitchell Collins 2) 3) 4) 5)

HOUSE OF REPRESENTATIVES STAFF ANALYSIS REFERENCE ACTION ANALYST STAFF DIRECTOR. 1) Health Care Mitchell Collins 2) 3) 4) 5) HOUSE OF REPRESENTATIVES STAFF ANALYSIS BILL #: HB 103 Medicinal Drug Prescriptions SPONSOR(S): Quinones TIED BILLS: IDEN./SIM. BILLS: SB 132 (i) REFERENCE ACTION ANALYST STAFF DIRECTOR 1) Health Care

More information

RULES OF THE ALABAMA BOARD OF MEDICAL EXAMINERS

RULES OF THE ALABAMA BOARD OF MEDICAL EXAMINERS RULES OF THE ALABAMA BOARD OF MEDICAL EXAMINERS CHAPTER 540-X-18 QUALIFIED ALABAMA CONTROLLED SUBSTANCES REGISTRATION CERTIFICATE (QACSC) FOR CERTIFIED REGISTERED NURSE PRACTITIONERS (CRNP) AND CERTIFIED

More information

64th Legislature AN ACT REVISING BOARD OF NURSING LAWS; PROVIDING FOR NURSING APPLICANTS TO SUBMIT TO

64th Legislature AN ACT REVISING BOARD OF NURSING LAWS; PROVIDING FOR NURSING APPLICANTS TO SUBMIT TO 64th Legislature HB0115 AN ACT REVISING BOARD OF NURSING LAWS; PROVIDING FOR NURSING APPLICANTS TO SUBMIT TO CRIMINAL BACKGROUND CHECKS; EXPANDING THE NURSING MEDICAL ASSISTANCE PROGRAM TO ALL LICENSEES;

More information

Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs

Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs Charlesworth Rae, BS, PharmD, JD Investigational Drug Pharmacist July 2012 1 Outline of Presentation I. Introduction

More information

Manitoba Prescribing Practices Program Pharmacist Questions and Answers

Manitoba Prescribing Practices Program Pharmacist Questions and Answers College of Pharmacists of Manitoba 200 Tache Avenue, Winnipeg, Manitoba R2H 1A7 Phone (204) 233-1411 Fax: (204) 237-3468 E-mail: info@cphm.ca Website: www.cphm.ca Manitoba Prescribing Practices Program

More information

Implementation of Florida s PDMP. Rebecca Poston Program Manager

Implementation of Florida s PDMP. Rebecca Poston Program Manager Implementation of Florida s PDMP Rebecca Poston Program Manager Disclaimer I have no relevant financial relationships or commercial interest in the content presented in this program. Learning Objectives:

More information

\ ~untv Administrator's Sionature:

\ ~untv Administrator's Sionature: BOARD OF COUNTY COMMISSIONERS DATE: September 23, 2014 AGENDA ITEM NO. _3{:;, Consent Agenda D Regular Agenda D Public Hearing ~ \ ~untv Administrator's Sionature: Subject: Public Hearing for a Proposed

More information

49 18.402 DEPARTMENT OF STATE Pt. I

49 18.402 DEPARTMENT OF STATE Pt. I 49 18.402 DEPARTMENT OF STATE Pt. I (3) The medical doctor has knowledge that the delegatee has education, training, experience and continued competency to safely perform the medical service being delegated.

More information

Controlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY

Controlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY 2015 Controlled Substance Policy and Procedures NORTHERN ILLINOIS UNIVERSITY OFFICE OF RESEARCH COMPLIANCE AND INTEGRITY Contents A. Controlled Substance Policy... 4 1. Background, Purpose, and Scope...

More information

MISSISSIPPI LEGISLATURE REGULAR SESSION 2016

MISSISSIPPI LEGISLATURE REGULAR SESSION 2016 MISSISSIPPI LEGISLATURE REGULAR SESSION 2016 By: Representative Mims To: Public Health and Human Services HOUSE BILL NO. 1187 1 AN ACT TO AMEND SECTION 73-25-34, MISSISSIPPI CODE OF 1972, 2 TO REVISE THE

More information

Practitioner s Manual

Practitioner s Manual United States Department of Justice Drug Enforcement Administration Office of Diversion Control An Informational Outline of the Controlled Substances Act Joseph T. Rannazzisi Deputy Assistant Administrator

More information

PLEASE READ. The official text of New Jersey Statutes can be found through the home page of the New Jersey Legislature http://www.njleg.state.nj.

PLEASE READ. The official text of New Jersey Statutes can be found through the home page of the New Jersey Legislature http://www.njleg.state.nj. PLEASE READ The official text of New Jersey Statutes can be found through the home page of the New Jersey Legislature http://www.njleg.state.nj.us/ New Jersey Statutes Annotated (N.J.S.A.), published by

More information

ARKANSAS PRODUCTS: PRODUCT EXEMPTIONS: SALES LIMITS: SALES RESTRICTIONS:

ARKANSAS PRODUCTS: PRODUCT EXEMPTIONS: SALES LIMITS: SALES RESTRICTIONS: ARKANSAS PRODUCTS: Any product containing ephedrine, pseudoephedrine, or phenylpropanolamine or any of their salts, isomers, or salts of isomers, alone or in a mixture. (A.C.A. 5-64-212) PRODUCT EXEMPTIONS:

More information

Kansas Statutes for School Health Services

Kansas Statutes for School Health Services Kansas Statutes for School Health Services Dental Screening 72-5201. Annual free dental inspection; exceptions. The boards of education of cities of the first and second class and school boards of school

More information

Board of Pharmacy Legislative Update Allison M. Dudley, J.D. Executive Director Board of Pharmacy. Disclosure. Objectives 9/9/2015

Board of Pharmacy Legislative Update Allison M. Dudley, J.D. Executive Director Board of Pharmacy. Disclosure. Objectives 9/9/2015 Board of Pharmacy Legislative Update Allison M. Dudley, J.D. Executive Director Board of Pharmacy Disclosure I have nothing to disclose and further, I was not paid an honorarium or travel reimbursement

More information

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION

02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION Effective June 13, 2010 02-313, 02-373, 02-380, 02-383, 02-396 Chapter 21 page 1 02 DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION 313 BOARD OF DENTAL EXAMINERS 373 BOARD OF LICENSURE IN MEDICINE

More information

SENATE BILL 1204 AN ACT

SENATE BILL 1204 AN ACT PLEASE NOTE: In most BUT NOT ALL instances, the page and line numbering of bills on this web site correspond to the page and line numbering of the official printed version of the bills. Senate Engrossed

More information

Health Professions Act BYLAWS SCHEDULE F. PART 3 Residential Care Facilities and Homes Standards of Practice. Table of Contents

Health Professions Act BYLAWS SCHEDULE F. PART 3 Residential Care Facilities and Homes Standards of Practice. Table of Contents Health Professions Act BYLAWS SCHEDULE F PART 3 Residential Care Facilities and Homes Standards of Practice Table of Contents 1. Application 2. Definitions 3. Supervision of Pharmacy Services in a Facility

More information

07 LC 33 1788 A BILL TO BE ENTITLED AN ACT BE IT ENACTED BY THE GENERAL ASSEMBLY OF GEORGIA:

07 LC 33 1788 A BILL TO BE ENTITLED AN ACT BE IT ENACTED BY THE GENERAL ASSEMBLY OF GEORGIA: 0 LC House Bill 0 By: Representative Stephens of the th A BILL TO BE ENTITLED AN ACT To amend Chapter of Title of the Official Code of Georgia Annotated, relating to pharmacists and pharmacies, so as to

More information

AMERICAN PSYCHOLOGICAL ASSOCIATION

AMERICAN PSYCHOLOGICAL ASSOCIATION A. Definitions AMERICAN PSYCHOLOGICAL ASSOCIATION MODEL LEGISLATION FOR PRESCRIPTIVE AUTHORITY Approved by APA Council of Representatives, 2009 (1) Board means the {state psychology licensing board}. (2)

More information

Date Submitted: July 20, 2000 Date Reviewed: May 31, 2005 January 17, 2006 March 17, 2009 Subject: Administration of Medication

Date Submitted: July 20, 2000 Date Reviewed: May 31, 2005 January 17, 2006 March 17, 2009 Subject: Administration of Medication POLICY SOMERSET COUNTY BOARD OF EDUCATION 1. PURPOSE Date Submitted: July 20, 2000 Date Reviewed: May 31, 2005 January 17, 2006 March 17, 2009 Subject: Administration of Medication Number: 600-32 Date

More information

TEXAS ~ STATUTE Continued

TEXAS ~ STATUTE Continued TEXAS ~ STATUTE STATUTE DATE Enacted 1981 REGULATORY BODY Texas Rev. Civ. Stat., Occupations Code, Chapter 204: Physician Assistant Licensing Act; Occupations Code Chapter 157; Authority of Physician to

More information

13 LC 33 5035S. The House Committee on Health and Human Services offers the following substitute to HB 178: A BILL TO BE ENTITLED AN ACT

13 LC 33 5035S. The House Committee on Health and Human Services offers the following substitute to HB 178: A BILL TO BE ENTITLED AN ACT The House Committee on Health and Human Services offers the following substitute to HB 178: A BILL TO BE ENTITLED AN ACT 1 2 3 4 5 6 7 8 9 10 11 To amend Chapter 34 of Title 43 of the Official Code of

More information

For a Healthier America: Reducing Prescription Drug Misuse and Abuse

For a Healthier America: Reducing Prescription Drug Misuse and Abuse For a Healthier America: Reducing Prescription Drug Misuse and Abuse The misuse and abuse of prescription medicines is a growing public health problem. In addition to the tragic toll on families and communities,

More information

Collaborative Practice Agreement for Nurse Practitioner Management of Patients in the Specialty of Pediatric Critical Care

Collaborative Practice Agreement for Nurse Practitioner Management of Patients in the Specialty of Pediatric Critical Care Collaborative Practice Agreement for Nurse Practitioner Management of Patients in the Specialty of Pediatric Critical Care Purpose Section I Introduction/Overview This document authorizes the nurse practitioner

More information

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES

FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES FREQUENTLY ASKED QUESTIONS FOR ELECTRONIC PRESCRIBING OF CONTROLLED SUBSTANCES EPCS Revised: October 2014 NEW YORK STATE DEPARTMENT OF HEALTH Bureau of Narcotic Enforcement 1-866-811-7957 www.health.ny.gov/professionals/narcotic

More information

51ST LEGISLATURE - STATE OF NEW MEXICO - SECOND SESSION, 2014

51ST LEGISLATURE - STATE OF NEW MEXICO - SECOND SESSION, 2014 HOUSE BILL 1ST LEGISLATURE - STATE OF NEW MEXICO - SECOND SESSION, INTRODUCED BY Thomas C. Taylor 1 AN ACT RELATING TO LICENSURE; PROVIDING FOR EXPEDITED LICENSURE FOR NURSES LICENSED IN OTHER STATES.

More information

NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS

NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS NOTICE REQUIREMENTS FOR PRESCRIPTION MONITORING PROGRAMS This project was supported by Grant No. G1299ONDCP03A, awarded by the Office of National Drug Control Policy. Points of view or opinions in this

More information

32-1921. Exempted acts; exemption from registration fees; definition

32-1921. Exempted acts; exemption from registration fees; definition AZ AT Act 32-1921. Exempted acts; exemption from registration fees; definition A. This chapter does not prevent: 1. The prescription and dispensing of drugs or prescription medications by a registered

More information

DIVISION 25 CERTIFIED OREGON PHARMACY TECHNICIANS AND PHARMACY TECHNICIANS

DIVISION 25 CERTIFIED OREGON PHARMACY TECHNICIANS AND PHARMACY TECHNICIANS 855-025-0001 DIVISION 25 CERTIFIED OREGON PHARMACY TECHNICIANS AND PHARMACY TECHNICIANS Purpose and Scope Transition from Registration of Technician to Licensure of Technician The purpose of the Pharmacy

More information

SAMPLE WRITTEN SUPERVISION AGREEMENT

SAMPLE WRITTEN SUPERVISION AGREEMENT A. Physician Assistant Information 1. Name: SAMPLE WRITTEN SUPERVISION AGREEMENT 2. Illinois PA License Number: Illinois Mid-Level Practitioner Controlled Substance License Number: Federal Mid-Level Practitioner

More information

ARIZONA ~ STATUTE -2522. Physician Assistants: State Laws and Regulations 10th edition, 2006 American Academy of Physician Assistants

ARIZONA ~ STATUTE -2522. Physician Assistants: State Laws and Regulations 10th edition, 2006 American Academy of Physician Assistants STATUTE 32-2501 et seq Arizona Revised Statutes DATE Enacted 1977 REGULATORY BODY Arizona Regulatory Board of Physician Assistants PA DEFINED Person licensed by the board who performs health care tasks

More information

Narcotic Treatment Programs

Narcotic Treatment Programs This is a copy of two small segments of the DEA Pharmacist Manual, April 2004. This material is absent from the DEA Practitioner s Manual. Narcotic Treatment Programs The Narcotic Addict Treatment Act

More information

DRUG REPOSITORY PROGRAM

DRUG REPOSITORY PROGRAM OHIO STATE BOARD OF PHARMACY 77 S. High Street, Room 1702; Columbus, OH 43215-6126 Tel: 614-466-4143 Email: exec@bop.state.oh.us DRUG REPOSITORY PROGRAM ORC - Ohio Revised Code OAC - Ohio Administrative

More information

How To Administer Medication In West Virginia

How To Administer Medication In West Virginia WOOD COUNTY BOARD OF EDUCATION Last Reviewed: July 18, 2006 Policy 5140 Medication Administration Next Review: July 18, 2008 I. Purpose A. Good health and safety are essential to student learning. The

More information

Schedule II Drug Program Law Component

Schedule II Drug Program Law Component Schedule II Drug Program Law Component. Analyzing State and Federal law and rules as they apply to the authority to prescribe schedule II drugs. Mary Jane Maloney MSN APRN Past President, OAAPN Schedule

More information

Schedule II Drug Program Law Component

Schedule II Drug Program Law Component Schedule II Law Component Schedule II Drug Program Law Component. Analyzing State and Federal law and rules as they apply to the authority to prescribe schedule II drugs. Pain Management Organizations

More information

Board of Pharmacy. Practical Experience (Intern Hours) Exam Requirements. Pharmacist Licensure. Continuing Education. Pharmacy Licensure Requirements

Board of Pharmacy. Practical Experience (Intern Hours) Exam Requirements. Pharmacist Licensure. Continuing Education. Pharmacy Licensure Requirements Board of Pharmacy Practical Experience (Intern Hours) Exam Requirements Pharmacist Licensure Continuing Education Pharmacy Licensure Requirements Prescribing Authority Alaska State Law Review -5 pharmacist

More information

Frequently Asked Questions (FAQs) Treatment Authorization Request (TAR) Restriction on Antipsychotic Medications for the 0-17 Population

Frequently Asked Questions (FAQs) Treatment Authorization Request (TAR) Restriction on Antipsychotic Medications for the 0-17 Population Frequently Asked Questions (FAQs) Treatment Authorization Request (TAR) Restriction on Antipsychotic Medications for the 0-17 Population Prescriber FAQs Update January 22, 2015 1. What information is needed

More information

HEALTH REQUIREMENTS & SERVICES: MEDICAL TREATMENT

HEALTH REQUIREMENTS & SERVICES: MEDICAL TREATMENT DESCRIPTOR TERM: Students Millard District Policy File Code: 6200 1 st Reading: 05-08-14 HEALTH REQUIREMENTS & SERVICES: MEDICAL TREATMENT Purpose The purpose of this policy is to authorize school personnel

More information

Delegation of Services Agreements Change in Regulations

Delegation of Services Agreements Change in Regulations Delegation of Services Agreements Change in Regulations Title 16, Division 13.8, Article 4, section 1399.540 was amended to include several requirements for the delegation of medical services to a physician

More information

RULES EFFECTIVE OCTOBER 27, 2011 SHOWING CHANGES

RULES EFFECTIVE OCTOBER 27, 2011 SHOWING CHANGES RULES EFFECTIVE OCTOBER 27, 2011 SHOWING CHANGES Index Page Rule No. Rule Title 4729- CHAPTER 4729-1 [ADMINISTRATIVE PROCEDURES] 1 1-02 Notice of meetings. 1 1-03 Public records. CHAPTER 4729-3 [PHARMACY

More information

State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program. User Support Manual

State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program. User Support Manual State of South Dakota Board of Pharmacy Prescription Drug Monitoring Program User Support Manual Contents 1 What Is a Requestor?... 3 2 Registration... 4 2.1 Registration Process... 4 2.2 Registering as

More information

Special payment rules for items furnished by DMEPOS suppliers and issuance of DMEPOS supplier billing privileges.

Special payment rules for items furnished by DMEPOS suppliers and issuance of DMEPOS supplier billing privileges. Special payment rules for items furnished by DMEPOS suppliers and issuance of DMEPOS supplier billing privileges. All Medicare DMEPOS suppliers must be in compliance with these Supplier Standards in order

More information

CHAPTER 27 THE SCOPE OF PROFESSIONAL NURSING PRACTICE AND ARNP AND CNM PROTOCOLS

CHAPTER 27 THE SCOPE OF PROFESSIONAL NURSING PRACTICE AND ARNP AND CNM PROTOCOLS I. INTRODUCTION CHAPTER 27 THE SCOPE OF PROFESSIONAL NURSING PRACTICE AND ARNP AND CNM PROTOCOLS Advance registered nurse practitioners (ARNPs) and clinical nurse practitioners (CNPs) have their scope

More information

A Request to Surrender a DEA Registration By Glen D. Crick, Attorney at Law

A Request to Surrender a DEA Registration By Glen D. Crick, Attorney at Law Knowledge replaces fear. A Request to Surrender a DEA Registration By Glen D. Crick, Attorney at Law Note: Though this article concerns requests made by federal Drug Enforcement Administration investigators

More information

COLORADO MEDICAL BOARD RULES AND REGULATIONS REGARDING THE PHYSICIAN S ROLE IN PRESCRIPTIVE AUTHORITY FOR ADVANCED PRACTICE NURSES

COLORADO MEDICAL BOARD RULES AND REGULATIONS REGARDING THE PHYSICIAN S ROLE IN PRESCRIPTIVE AUTHORITY FOR ADVANCED PRACTICE NURSES Rule 950 3 CCR 713-37 COLORADO MEDICAL BOARD RULES AND REGULATIONS REGARDING THE PHYSICIAN S ROLE IN PRESCRIPTIVE AUTHORITY FOR ADVANCED PRACTICE NURSES Basis: The authority for the promulgation of these

More information

REGULATION 3 PHARMACY TECHNICIANS

REGULATION 3 PHARMACY TECHNICIANS REGULATION 3 PHARMACY TECHNICIANS 03-00 PHARMACY TECHNICIANS REGISTRATION/PERMIT REQUIRED 03-00-0001 DEFINITIONS (a) Pharmacy technician means those individuals, exclusive of pharmacy interns, who assist

More information